Showing results (471-480 of 573) with videos related to
Sort By:
Pageof 58
Plos One|December 24, 2014
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implicationsChaitanya R Churi, Rachna Shroff, Ying Wang, et al.Circulation. Cardiovascular Interventions|February 27, 2023
Prognostic Impact of Coronary Microvascular Dysfunction According to Different Patterns by Invasive Physiologic Indexes in Symptomatic Patients With Intermediate Coronary StenosisDavid Hong, Doosup Shin, Seung Hun Lee, et al.Revista Espanola De Cardiologia (English Ed.)|March 5, 2025
Efficacy and safety of SGLT2 inhibitors in patients with heart failure according to kidney function: a systematic review and meta-analysisDavid Hong, Minseok Hong, Onyou Kim, et al.Journal of the American Heart Association|January 25, 2023
Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function on Cardiovascular DeathDavid Hong, Seung Hun Lee, Doosup Shin, et al.Oncotargets and Therapy|May 17, 2021
A Phase I Trial of the MET/ALK/ROS1 Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid MalignanciesSarina A Piha-Paul, Ecaterina E Dumbrava, Binoj C Nair, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 19, 2006
Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorderSoyoung Irene Lee, Sungdo David Hong, Sang-Yeup Kim, et al.Biorxiv : the Preprint Server for Biology|April 17, 2026
KRAS inhibition is an effective therapy for appendiceal adenocarcinomaSaikat Chowdhury, Ichiaki Ito, Vinay K Pattalachinti, et al.The Lancet. Oncology|September 7, 2025
Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trialChad Tang, Alexander D Sherry, Aaron Seo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2026
Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Solid Tumors: Primary Analysis of All Tumor-Histology Baskets of the Phase II Randomized EXTEND TrialAlexander D Sherry, Cara Haymaker, Shuqi Wang, et al.Kidney International Reports|January 16, 2023
Prognostic Impact of Coronary Flow Reserve in Patients With CKDSugeon Park, Seung Hun Lee, Doosup Shin, et al.Pageof 58